Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2009 | 1 |
2010 | 1 |
2011 | 3 |
2012 | 3 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma.
J Neurooncol. 2012 Mar;107(1):155-64. doi: 10.1007/s11060-011-0722-2. Epub 2011 Oct 11.
J Neurooncol. 2012.
PMID: 21986722
Free PMC article.
Clinical Trial.
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients.
Reardon DA, Herndon JE 2nd, Peters KB, Desjardins A, Coan A, Lou E, Sumrall AL, Turner S, Lipp ES, Sathornsumetee S, Rich JN, Sampson JH, Friedman AH, Boulton ST, Bigner DD, Friedman HS, Vredenburgh JJ.
Reardon DA, et al.
Br J Cancer. 2012 Oct 23;107(9):1481-7. doi: 10.1038/bjc.2012.415. Epub 2012 Oct 4.
Br J Cancer. 2012.
PMID: 23037712
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.
Reardon DA, Desjardins A, Peters KB, Vredenburgh JJ, Gururangan S, Sampson JH, McLendon RE, Herndon JE 2nd, Coan A, Threatt S, Friedman AH, Friedman HS.
Reardon DA, et al.
Cancer. 2011 Dec 1;117(23):5351-8. doi: 10.1002/cncr.26188. Epub 2011 May 16.
Cancer. 2011.
PMID: 21590689
Free PMC article.
Clinical Trial.
Item in Clipboard
Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series.
Lou E, Sumrall AL, Turner S, Peters KB, Desjardins A, Vredenburgh JJ, McLendon RE, Herndon JE 2nd, McSherry F, Norfleet J, Friedman HS, Reardon DA.
Lou E, et al.
J Neurooncol. 2012 Aug;109(1):63-70. doi: 10.1007/s11060-012-0861-0. Epub 2012 Apr 26.
J Neurooncol. 2012.
PMID: 22535433
Free PMC article.
Item in Clipboard
Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
Sok JC, Coppelli FM, Thomas SM, Lango MN, Xi S, Hunt JL, Freilino ML, Graner MW, Wikstrand CJ, Bigner DD, Gooding WE, Furnari FB, Grandis JR.
Sok JC, et al.
Clin Cancer Res. 2006 Sep 1;12(17):5064-73. doi: 10.1158/1078-0432.CCR-06-0913.
Clin Cancer Res. 2006.
PMID: 16951222
Item in Clipboard
Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.
Reardon DA, Desjardins A, Peters K, Gururangan S, Sampson J, Rich JN, McLendon R, Herndon JE 2nd, Marcello J, Threatt S, Friedman AH, Vredenburgh JJ, Friedman HS.
Reardon DA, et al.
J Neurooncol. 2011 Jun;103(2):371-9. doi: 10.1007/s11060-010-0403-6. Epub 2010 Sep 19.
J Neurooncol. 2011.
PMID: 20853132
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma.
Reardon DA, Egorin MJ, Desjardins A, Vredenburgh JJ, Beumer JH, Lagattuta TF, Gururangan S, Herndon JE 2nd, Salvado AJ, Friedman HS.
Reardon DA, et al.
Cancer. 2009 May 15;115(10):2188-98. doi: 10.1002/cncr.24213.
Cancer. 2009.
PMID: 19248046
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite